SPONSORED CONTENT
At the 340B Coalition winter conference last month, two major topics were impossible
…Articles by : Sponsored Content,
SPONSORED CONTENT
A HRSA audit is not a question of if but when. Therefore, it is crucial for covered entities (CEs) to always remain audit-ready. The 340B program has become increasingly complex over the years, prompting service provider partners (partners) in the
…SPONSORED CONTENT
W. Edwards Deming is a renowned statistician and expert in quality management. He is often quoted as saying, “Uncontrolled variation is the enemy of quality.” In the realm of 340B, including 340B contract pharmacies, that change is both continual and constant.
…SPONSORED CONTENT
Let me start by saying that I have been to the 340B Coalition conferences since 2012, and every year entities have feared significant changes and the threat of problematic legislation becoming law. Fortunately,
…SPONSORED CONTENT
The 340B program serves as a critical resource for hospitals and other safety net providers striving to provide comprehensive care to their patient populations. However, evolving operational requirements make it essential for covered entities to develop programs that are both scalable and
…SPONSORED CONTENT
The 340B program has come under increased scrutiny within the past five years. Opponents often claim it is misused by covered entities (CEs) to generate profits rather than help vulnerable patients. These criticisms often come from a misunderstanding of
…
SPONSORED CONTENT
TIP: Take time to focus on these three important fundamentals of 340B program compliance and integrity.
Update
SPONSORED CONTENT
The 340B Drug Pricing Program is at a crossroads, facing increased scrutiny, manufacturer restrictions, and ongoing legal battles. In this must-watch webinar, industry experts Ted Slafsky (340B Report), Emily Cook (McDermott, Will & Emery), and Nicole Shoquist (JPS Health Network) break down the
… SPONSORED CONTENT
TIP: Master manufacturer refund challenges with actionable steps.
Managing manufacturer refunds in the 340B Drug Pricing Program
SPONSORED CONTENT
The healthcare landscape is evolving rapidly, and with it, the need for stronger, smarter partnerships has never been greater. Covered entities are navigating a time of uncertainty, where operational challenges, regulatory scrutiny, and resource constraints are putting unprecedented pressure on healthcare organizations. That’s why
…